Trial Profile
Mk0476 [montelukast] phase II dose finding study -allergic rhinitis-
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Merck & Co; Organon
- 02 May 2007 New trial record.